US Congress Senate Bill 1674 (Prior Session Legislation)

---

Completed Legislative Action
Spectrum: Slight Partisan Bill (Democrat 15-7)
Status: Passed on October 5 2010 - 100% progression
Action: 2010-10-05 - Became Public Law No: 111-255.
Text: Latest bill text (Engrossed) [PDF]

Improving Access to Clinical Trials Act of 2009 - Amends title XVI (Supplemental Security Income) (SSI) of the Social Security Act (SSA) to exclude from income for SSI eligibility purposes any compensation in the amount of the first $2,000 per year received by an individual for participation in clinical trials involving research and testing of treatments for rare diseases or conditions. Amends SSA title XIX (Medicaid) to make a similar exclusion from income of such compensation for the purposes of eligibility under the Medicaid program. Directs the Comptroller General to study and report to Congress on the impact of this Act on enrollment of individuals who receive SSI benefits in clinical trials for rare diseases or conditions.

Improving Access to Clinical Trials Act of 2009

Sen. Barbara Boxer [D-CA]	Sen. Sherrod Brown [D-OH]	Sen. Sam Brownback [R-KS]	Sen. Richard Burr [R-NC]
Sen. Roland Burris [D-IL]	Sen. Tom Coburn [R-OK]	Sen. Christopher Dodd [D-CT]	Sen. Richard Durbin [D-IL]
Sen. Dianne Feinstein [D-CA]	Sen. Al Franken [D-MN]	Sen. James Inhofe [R-OK]	Sen. Tim Johnson [D-SD]
Sen. John Kerry [D-MA]	Sen. Amy Klobuchar [D-MN]	Sen. Frank Lautenberg [D-NJ]	Sen. Blanche Lincoln [D-AR]
Sen. Robert Menendez [D-NJ]	Sen. Jeff Merkley [D-OR]	Sen. Lisa Murkowski [R-AK]	Sen. Pat Roberts [R-KS]
Sen. Richard Shelby [R-AL]	Sen. Ron Wyden [D-OR]

Date	Chamber	Action
2010-10-05		Became Public Law No: 111-255.
2010-10-05		Signed by President.
2010-09-24		Presented to President.
2010-09-23		Cleared for White House.
2010-09-23		Motion to reconsider laid on the table Agreed to without objection.
2010-09-23		On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H6892)
2010-09-23		DEBATE - The House proceeded with forty minutes of debate on S. 1674.
2010-09-23		Considered under suspension of the rules. (consideration: CR H6891-6896)
2010-09-23		Mr. McDermott moved to suspend the rules and pass the bill.
2010-08-09		Held at the desk.
2010-08-09		Received in the House.
2010-08-06		Message on Senate action sent to the House.
2010-08-05		Passed Senate without amendment by Unanimous Consent. (text: CR S6979-6980)
2010-08-05		Senate Committee on Finance discharged by Unanimous Consent. (consideration: CR S6979-6980)
2009-09-15		Read twice and referred to the Committee on Finance.
2009-09-15		Sponsor introductory remarks on measure. (CR S9379)

HB2866 (Related) 2009-06-15 - Referred to the House Committee on Ways and Means.

Type	Source
Summary	https://www.congress.gov/bill/111th-congress/senate-bill/1674/all-info
Text	https://www.congress.gov/111/bills/s1674/BILLS-111s1674is.pdf
Text	https://www.congress.gov/111/bills/s1674/BILLS-111s1674es.pdf
Text	https://www.congress.gov/111/bills/s1674/BILLS-111s1674enr.pdf